Study Stopped
Study withdrawn prior to enrollment due to lack of available financial resources.
Blood Flow Restriction Therapy Improves Tibial Plateau Fracture Recovery
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The goal of this clinical trial is to investigates the effectiveness of physical therapy augmented with blood flow restriction (BFR) therapy relative to standard physical therapy in patients after an open reduction and internal fixation of a closed tibial plateau fracture. The main aims are:
- Collect functional and patient self-reported outcomes data
- Assess leg muscle atrophy
- Acquire motion analysis dynamics and knee strength data. Participants will be randomized into either a rehabilitation protocol or that protocol with blood flow restriction and be followed for 1 year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
November 10, 2025
November 1, 2025
2 years
July 15, 2024
November 6, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Collect participant knee injury consequences questionnaire
Participants will complete the KOOS (Knee Injury and Osteoarthritis Outcome Score) questionnaire.
Prior to initiation of therapy, and 3, 6, and 12 months postoperatively
Collect participant reported function outcome questionnaire
Participants will complete the PROMIS PF (Patient-Reported Outcomes Measurement Information System Physical Function) questionnaire.
Prior to initiation of therapy, and 3, 6, and 12 months postoperatively
Assess leg muscle atrophy
Bilateral thigh and calf circumferential girth measurements will be taken once prior to initiation of therapy and then additionally at 3, 6, and 12 months postoperatively as a surrogate for muscle mass.
Prior to initiation of therapy and 3, 6, and 12 months postoperatively
Acquire motion analysis dynamics
Participants will undergo 3D motion analysis with concurrent surface EMG (i.e., the electrical activity of the muscle) during walking, sit-to-stand, forward lunge, and step-up-and-over tasks.
6 and 12 months postoperatively.
Acquire knee strength data.
Bilateral knee strength (i.e., muscle force production) will be assessed for isometric, concentric and eccentric muscle contractions using a Biodex dynamometer.
6 and 12 months postoperatively.
Study Arms (2)
Rehabilitation Protocol
ACTIVE COMPARATORStandard physical therapy will be performed according to the clinic standard with manual lymphatic drainage, cryotherapy, and 20 minutes of physical therapy two times a week for fourteen weeks following the initial post-operative visit.
Rehabilitation Protocol and Blood Flow Restriction
EXPERIMENTALIn addition to the standard physical therapy, the blood flow restriction group will also begin standard physical therapy care supplemented with blood flow restriction therapy two times a week for 10 weeks after wound healing.
Interventions
The standardized exercises will be performed while wearing a blood flow restriction cuff.
Standard physical therapy
Eligibility Criteria
You may qualify if:
- Equal to or greater than 18 years of age
- ORIF (open reduction and internal fixation) of a closed unicondylar tibial plateau fracture
- Planning to attend physical therapy at one of the eligible Froedtert locations with BFR therapy capabilities
You may not qualify if:
- Patient is unable to provide consent
- At time of tibial plateau fracture has evidence of a(n)
- Open fracture(s)
- Fracture(s) with associated vascular injury,
- Fracture(s) with extensive soft tissue injury preventing the ability to apply a tourniquet
- Ipsilateral or contralateral lower extremity fracture(s)
- Pelvic or spinal trauma
- History of deep venous thrombosis (DVT)
- History of peripheral vascular disease
- Body Mass Index \> 40
- Any history of condition that would affect the patient's ability to bear weight as tolerated post-operatively.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth Nolte, MD
Medical College of Wisconsin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 15, 2024
First Posted
September 19, 2024
Study Start
December 1, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
November 10, 2025
Record last verified: 2025-11